Regulatory Updates

The QbD Group regulatory updates blog provides professionals in the life sciences with timely and insightful information on the latest regulatory trends, guidelines, and compliance requirements. Covering topics from pharmaceutical manufacturing standards to medical device approvals, the blog aims to support readers in navigating complex regulatory landscapes, ensuring product safety, and accelerating time to market. Whether you're involved in quality assurance, regulatory affairs, or product development, this blog offers valuable resources to keep you informed and compliant.

Regulatory Updates

Why-self-inspections-or-internal-audits-are-essential-for-your-QMS-1536x864
Circles_banner_news&events

Pablo Palomar, Senior Toxicology Officer at QbD Group

Recent Posts

New Update of Appendix 1 of the Nitrosamines Guideline - EMA/42261/2025/Rev. 11

FDA Deadline Update - Risk of nitrosamine drug substance-related impurity (NDSRI)

Nitrosamines Update EMA/409815/2020 Rev.22

The FDA releases revision of guidance regarding Control of Nitrosamine Impurities in Human Drugs

New Update of Appendix 1 of the Nitrosamines Guideline

Latest Update on Appendix 1 of the Nitrosamine Guidelines

data-not-found No Items Found! Please Try Some Different Keywords
circle news